Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Sarcoma

NCT00002974 2019-12-13

Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma

Phase 2 Completed

34 enrolled

Sarcoma

NCT00004136 2018-11-06

Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Phase 2 Completed

59 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT03644524 2018-08-23

CMH

Phase NA Completed

20 enrolled

Other

Hyperthermia, Obesity, Polycystic Ovary Syndrome, Prediabetic State, Metabolic Syndrome, Prehypertension

NCT00003045 2017-04-26

Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer

Phase NA Completed

38 enrolled

Genitourinary

Prostatic Neoplasms

NCT00769405 2016-08-30

Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer

Phase 3 Completed

264 enrolled

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01551433 2016-08-18

Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy

Completed

166 enrolled

Gastrointestinal

Esophageal Neoplasms, Anastomotic Leak

NCT00876954 2016-01-21

Preoperative Hyperthermia in Major Abdominal Surgery Patients

Phase 1/2 Completed

20 enrolled

Gastrointestinal

Colonic Neoplasms

NCT00002973 2015-10-02

Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma

Phase 2 Completed

34 enrolled

Dermatologic

Melanoma

NCT00093509 2014-09-01

MRI Sarcoma Non Invasive Thermometry

Phase 1/2 Completed

15 enrolled

Sarcoma

NCT01092468 2011-10-04

Comparison of Harmonic Scalpel to Conventional Diathermy in Perforator Flap Elevation for Head and Neck Reconstruction

Phase 2 Completed

20 enrolled

Tumor-Agnostic

Neoplasms